BML Capital Management, LLC
Position in CNTB — Connect Biopharma Holdings Ltd
CIK 1616824
ZIONSVILLE, IN
Position in CNTB
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$1,364,423
+$293,140 QoQ
Shares Held
573,287
+40.2% QoQ
Ownership
0.910%
of shares outstanding
% of Portfolio
0.78%
of 13F equity value
Holder Rank
#7
of 55 holders
Holding Since
Sep 2025
4 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in CNTB Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026BML Capital Management, LLC holds $130,180,167 across 10 Biotechnology names. CNTB ranks #9 (1.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ACRS |
Aclaris Therapeutics, Inc.
|
11,975,000 | $63,347,750 | |
| 2 | AVIR |
Atea Pharmaceuticals, Inc.
|
6,952,330 | $32,328,334 | |
| 3 | ENGN |
enGene Therapeutics Inc.
|
6,669,908 | $11,538,940 | |
| 4 | PMVP |
PMV Pharmaceuticals, Inc.
|
5,330,000 | $7,142,200 | |
| 5 | TIL |
Instil Bio, Inc.
|
645,600 | $4,964,664 | |
| 6 | ORMP |
Oramed Pharmaceuticals Inc.
|
866,269 | $4,166,753 | |
| 7 | JANX |
Janux Therapeutics, Inc.
|
154,961 | $2,380,200 | |
| 8 | PLRX |
Pliant Therapeutics, Inc.
|
1,546,137 | $1,762,596 |
All Filings in CNTB
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,364,423 | 573,287 | Shares | Sole | 2026-08-07 | |
| 2026-03-31 | $1,071,283 | 408,887 | Shares | Sole | 2026-05-06 | |
| 2025-12-31 | $1,153,061 | 408,887 | Shares | Sole | 2026-02-03 | |
| 2025-09-30 | $1,913,925 | 1,267,500 | Shares | Sole | 2025-11-10 | |
| No filing history on record for this holder in this stock. | ||||||